Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?

被引：36

作者：

Bresalier, Robert S. ^{[1
]}

Kopetz, Scott ^{[2
]}

Brenner, Dean E. ^{[3
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA

[3] Univ Michigan, Dept Med Oncol, Ann Arbor, MI 48109 USA

来源：

DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 03期

关键词：

Colon cancer; Screening; Blood-based markers; Fecal occult blood testing; ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED ANTIGEN; SEPTIN; 9; DNA; COLON-CANCER; GLYCOPROTEIN MICROARRAYS; BINDING PROTEIN-3; POTENTIAL MARKER; PLASMA-INSULIN; FACTOR-I; SERUM;

D O I：

10.1007/s10620-015-3575-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Colorectal cancer is the second leading cause of cancer death in industrialized nations, accounting for 10 % of the total cancer burden with an individual lifetime risk of similar to 6 % in the USA (Siegel et al. in CA Cancer J Clin 62:9-29, 2014, American Cancer Society in Colorectal cancer facts and figures 2011-2013. American Cancer Society, Atlanta, 2011, Siegel et al. in CA Cancer J Clin 61:212-236, 2011). Although numerous screening methods have been incorporated into guidelines for colorectal cancer screening, no guideline includes a noninvasive blood-based test as a recommended option.

引用

页码：664 / 671

页数：8

共 66 条

[51] Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature [J].

Sanduleanu, S. ;

le Clercq, C. M. C. ;

Dekker, E. ;

Meijer, G. A. ;

Rabeneck, L. ;

Rutter, M. D. ;

Valori, R. ;

Young, G. P. ;

Schoen, R. E. .

GUT, 2015, 64 (08) :1257-U203

[52]

Scanlan MJ, 2002, CANCER RES, V62, P4041

[53] The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths [J].

Siegel, Rebecca ;

Ward, Elizabeth ;

Brawley, Otis ;

Jemal, Ahmedin .

CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (04) :212-236

[54]

Souverijn JHM, 2014, NEW ENGL J MED, V371, P187, DOI [10.1056/NEJMc1405215, 10.1056/NEJMoa1311194]

[55] On the Development of Plasma Protein Biomarkers [J].

Surinova, Silvia ;

Schiess, Ralph ;

Huettenhain, Ruth ;

Cerciello, Ferdinando ;

Wollscheid, Bernd ;

Aebersold, Ruedi .

JOURNAL OF PROTEOME RESEARCH, 2011, 10 (01) :5-16

[56]

Takeda A, 2000, ONCOL REP, V7, P333

[57] Sensitivity Estimates of Blood-Based Tests for Colorectal Cancer Detection: Impact of Overrepresentation of Advanced Stage Disease [J].

Tao, Sha ;

Hundt, Sabrina ;

Haug, Ulrike ;

Brenner, Hermann .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (02) :242-253

[58] Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers [J].

Toth, Kinga ;

Sipos, Ferenc ;

Kalmar, Alexandra ;

Patai, Arpad V. ;

Wichmann, Barnabas ;

Stoehr, Robert ;

Golcher, Henriette ;

Schellerer, Vera ;

Tulassay, Zsolt ;

Molnar, Bela .

PLOS ONE, 2012, 7 (09)

[59] Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group [J].

Tuck, Melissa K. ;

Chan, Daniel W. ;

Chia, David ;

Godwin, Andrew K. ;

Grizzle, William E. ;

Krueger, Karl E. ;

Rom, William ;

Sanda, Martin ;

Sorbara, Lynn ;

Stass, Sanford ;

Wang, Wendy ;

Brenner, Dean E. .

JOURNAL OF PROTEOME RESEARCH, 2009, 8 (01) :113-117

[60] Cancer Genome Landscapes [J].

Vogelstein, Bert ;

Papadopoulos, Nickolas ;

Velculescu, Victor E. ;

Zhou, Shibin ;

Diaz, Luis A., Jr. ;

Kinzler, Kenneth W. .

SCIENCE, 2013, 339 (6127) :1546-1558

← 1 2 3 4 5 6 7 →